Granite Pharmaceuticals Private Limited
About Granite Pharmaceuticals Private Limited
Data last updated:
Granite Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 16 December 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24230BR2014PTC023350. Its GSTIN is 10AAFCG8427M1ZI (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Rohit Kumar Shrivastav (Managing Director) and Kumar Shailesh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Savita Sadan Priyadarsi Nagar Tower Gali Naya Tola Kumhrar, Patna, Bihar, India – 800026.
As per the financials filed for FY 2025, the company reported a revenue of ₹96,921, a decline of 71% compared to the previous year. For the same year it recorded a net loss of ₹39,783 (net margin -41%) and EBITDA of -₹38,837 (EBITDA margin -40.1%). Revenue has declined at a compounded annual rate (CAGR) of 24% over three years and 33% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Granite Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSavita Sadan Priyadarsi Nagar Tower Gali Naya Tola Kumhrar, Patna, Bihar, India – 800026
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Granite Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Granite Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Granite Pharmaceuticals Private Limited, buy the company report.
Financials of Granite Pharmaceuticals Private Limited
FY 2025 filings availableGranite Pharmaceuticals Private Limited reported revenue of ₹96,921 (down 71% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 33% over five years, including a 71% fall in the latest year. EBITDA rose 59% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹38,837 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹39,783 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -40.1% | ||||
| Net Profit Margin | -41% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Granite Pharmaceuticals Private Limited, buy the company report.
Board of directors of Granite Pharmaceuticals Private Limited
Granite Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kumar Shailesh | Director | 16 Dec 2014 | 11 Years 10 Months | Current |
| Rohit Kumar Shrivastav Also directs: Zuventa Pharmaceuticals Private Limited | Managing Director | 16 Dec 2014 | 11 Years 10 Months | Current |
Peer comparison
Granite Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Darovya Pharmaceuticals Private Limited | ₹98,186 (FY 2018) | Greater Noida, Uttar Pradesh, India | ||||
| Nivabs Pharmaceuticals Private Limited | ₹98,000 (FY 2024) | -41.0% | Rudarpur, Uttarakhand, India | |||
| Granite Pharmaceuticals Private Limitedthis company | ₹96,921 (FY 2025) | -₹39,783 | -41% | -71.0% | Patna, Bihar, India | |
| Medglobe Pharmaceuticals Private Limited | ₹96,163 (FY 2024) | Noida, Uttar Pradesh, India |
To see the full peer comparison of Granite Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Granite Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Granite Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Granite Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Granite Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Granite Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAFCG8427M1ZI | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Granite Pharmaceuticals Private Limited, buy the company report.
Recent activity
Granite Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Kumar Shailesh was appointed as Director on 16 Dec 2014.
Frequently asked questions
Granite Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in other wholesale, within the trading industry. It was incorporated on 16 December 2014 (12+ years old) and is registered under CIN U24230BR2014PTC023350.
Granite Pharmaceuticals has 2 current directors:
- Rohit Kumar Shrivastav - Managing Director
- Kumar Shailesh - Director
The latest financial statements of Granite Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Granite Pharmaceuticals is 10AAFCG8427M1ZI, registered in Bihar.
The CIN (Corporate Identification Number) of Granite Pharmaceuticals is U24230BR2014PTC023350. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Granite Pharmaceuticals was incorporated on 16 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Granite Pharmaceuticals by revenue are Darovya Pharmaceuticals Private Limited, Nivabs Pharmaceuticals Private Limited, Medglobe Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Kumar Shailesh was appointed as Director on 16 Dec 2014. Rohit Kumar Shrivastav was appointed as Managing Director on 16 Dec 2014.
The registered office of Granite Pharmaceuticals is at Savita Sadan Priyadarsi Nagar Tower Gali Naya Tola Kumhrar, Patna, Bihar, India – 800026.
Granite Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Granite Pharmaceuticals is compliant as of 12 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
